A NEW treatment for patients with breathing problems, which is delivered in a revamped inhaler, has been approved for use on the NHS in Scotland.
The Scottish Medicines Consortium backed the use of aclidinium for sufferers of chronic obstructive pulmonary disease (COPD) – a disabling lung condition that affects 100,000 people living in Scotland.
The inhaler has been designed to prevent patients accidentally double-dosing or using the device when it is empty, by signalling when the drug has been delivered through a coloured window.
We moderate all comments on HeraldScotland on either a pre-moderated or post-moderated basis. If you're a relatively new user then your comments will be reviewed before publication and if we know you well then your comments will be subject to moderation only if other users or the moderators believe you've broken the rules, which are available here.
Moderation is undertaken full-time 9am-6pm on weekdays, and on a part-time basis outwith those hours. Please be patient if your posts are not approved instantly.
